Similar articles for PMID: 27647616

Year	Number of Results
2003	1
2010	2
2011	2
2012	4
2013	4
2014	4
2015	4
2016	4
2017	10
2018	13
2019	19
2020	10
2021	9
2022	20
2023	12
2024	4

1

Caring for patients with opioid use disorder in the hospital.

Donroe JH, Holt SR, Tetrault JM. Donroe JH, et al. CMAJ. 2016 Dec 6;188(17-18):1232-1239. doi: 10.1503/cmaj.160290. Epub 2016 Sep 19. CMAJ. 2016. PMID: 27647616 Free PMC article. Review. No abstract available.

2

Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.

Soyka M, Hillemacher T. Soyka M, et al. Addiction. 2014 Jan;109(1):88-9. doi: 10.1111/add.12376. Addiction. 2014. PMID: 24438113 No abstract available.

3

Flexible Buprenorphine/Naloxone Treatment Models: Safe and Effective in Reducing Opioid Use Among Persons With Prescription Opioid Use Disorder.

Saunders EC. Saunders EC. Am J Psychiatry. 2022 Oct;179(10):699-701. doi: 10.1176/appi.ajp.20220687. Am J Psychiatry. 2022. PMID: 36181331 Free PMC article. No abstract available.

4

Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.

Cottrill CB, Matson SC. Cottrill CB, et al. Adolesc Med State Art Rev. 2014 Aug;25(2):251-65. Adolesc Med State Art Rev. 2014. PMID: 27132312 Review. No abstract available.

5

Prevention of Opioid Overdose.

Babu KM, Brent J, Juurlink DN. Babu KM, et al. N Engl J Med. 2019 Jun 6;380(23):2246-2255. doi: 10.1056/NEJMra1807054. N Engl J Med. 2019. PMID: 31167053 Review. No abstract available.

6

Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.

Herscher M, Fine M, Navalurkar R, Hirt L, Wang L. Herscher M, et al. Med Clin North Am. 2020 Jul;104(4):695-708. doi: 10.1016/j.mcna.2020.03.003. Epub 2020 May 12. Med Clin North Am. 2020. PMID: 32505261 Review.

7

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.

Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Bruneau J, Fischer B, Rehm J, Wild TC, Wood E, Brissette S, Gagnon L, Fikowski J, Ledjiar O, Masse B, Socias ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Jutras-Aswad D, et al. Am J Psychiatry. 2022 Oct;179(10):726-739. doi: 10.1176/appi.ajp.21090964. Epub 2022 Jun 15. Am J Psychiatry. 2022. PMID: 35702828 Clinical Trial.

8

Use and misuse of opioid replacement therapies: a Queensland study.

Smirnov A, Kemp R. Smirnov A, et al. Subst Use Misuse. 2012 Jan;47(1):78-85. doi: 10.3109/10826084.2011.629017. Subst Use Misuse. 2012. PMID: 22216993

9

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.

Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, Jacobs P, Teruya C, McLaughlin P, Wiest K, Cohen A, Ling W. Hser YI, et al. Addiction. 2014 Jan;109(1):79-87. doi: 10.1111/add.12333. Epub 2013 Oct 9. Addiction. 2014. PMID: 23961726 Free PMC article. Clinical Trial.

10

Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report.

Martell JP, Konakanchi JS, Sethi R. Martell JP, et al. J Addict Dis. 2022 Jul-Sep;40(3):439-443. doi: 10.1080/10550887.2021.1996153. Epub 2022 Jan 24. J Addict Dis. 2022. PMID: 35072589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year